机译:IDH1突变足以建立神经胶质瘤高甲基化者表型
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Weill Cornell College of Medicine, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA;
Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Genomics Core, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Weill Cornell College of Medicine, New York, New York 10065, USA,Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Weill Cornell College of Medicine, New York, New York 10065, USA,Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA,Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;
机译:SDH突变在副神经节瘤中建立一个hypermethylator表型。
机译:p.R132残基上的IDH1突变(IDH1(R132))在高级神经胶质瘤中频繁发生,而在其他实体瘤中则不常见。
机译:代谢基因IDH1,IDH2和SDHAF2的突变不是散发性嗜铬细胞瘤和神经节旁假性低氧表型的主要决定因素。
机译:深度卷积神经网络预测低级胶质瘤中MRI的1P19Q共缺失和IDH1突变状态
机译:针对具有IDH1突变的神经胶质瘤:利用独特的代谢特征
机译:IDH1突变足以建立胶质瘤hypermethylator表型
机译:SDH突变在副神经节瘤中建立一个hypermethylator表型。